Learn more about Optate, a first-in-class medication for treating respiratory infection by SARS-Cov-2, the coronavirus responsible for COVID-19. Prospective investors or drug companies interested in partnering with us in developing our therapeutic Optate may contact Airbase Breathing Company, LLC, (also known as Airbase BC) through our website.